Viewing Study NCT03151057


Ignite Creation Date: 2025-12-24 @ 6:46 PM
Ignite Modification Date: 2026-01-02 @ 1:35 AM
Study NCT ID: NCT03151057
Status: TERMINATED
Last Update Posted: 2024-03-12
First Post: 2017-03-29
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization: